Viemed Healthcare, Inc.

Viemed Healthcare, Inc. (NASDAQ: VMD) is a provider of home medical equipment and post-acute healthcare services throughout the United States, with a focus on respiratory, chronic care, and women's health products and services. The company operates through a technology-enabled, home-based clinical care and chronic disease management model designed to treat patients in their homes at lower total cost while delivering superior quality of care compared to traditional settings. www.viemed.com

The company's primary service offerings include respiratory disease management for conditions such as chronic obstructive pulmonary disease, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, women's health products including breast pumps and lactation equipment, and healthcare staffing services. Monthly rental revenue from ventilators represented approximately 51 percent of total revenue, while revenues from Medicare and Medicaid accounted for 40 percent of revenue. Viemed sources respiratory equipment from vendors and pairs it with industry-leading respiratory therapy delivered by licensed respiratory therapists who are members of the American Association for Respiratory Care.

As of December 31, 2025, Viemed employed 1,382 permanent employees, with 401 licensed respiratory therapists representing approximately 29 percent of the company-wide employee count. The company serves patients across all 50 states of the United States and operates through a distributed model that emphasizes personnel costs for patient-facing clinical practitioners rather than physical location expenses, enabling efficient scaling into underserved territories.

Viemed maintains Medicare accreditation as a Durable Medical Equipment, Prosthetics, Orthotics, and Supplies supplier and operates under extensive federal and state regulatory frameworks governing reimbursement, fraud prevention, and healthcare compliance. The company finances patient-related capital expenditures through cash generated from operations or through commercial credit facilities comprising a revolving credit facility of up to 30 million dollars, a delayed draw term loan facility of up to 30 million dollars, and an accordion feature allowing increases up to an additional 30 million dollars. Viemed is incorporated in British Columbia and trades on the Nasdaq Stock Market LLC under the trading symbol VMD.